| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8816453 | American Journal of Preventive Medicine | 2018 | 9 Pages |
Abstract
The 3-month isoniazid-rifapentine regimen is as safe and effective as other recommended latent tuberculosis infection regimens and achieves significantly higher treatment completion rates.
Related Topics
Health Sciences
Medicine and Dentistry
Public Health and Health Policy
Authors
Gibril J. MPH, Sapna Bamrah MD, MBA, Rachel Yelk MPH, Ruth N. MD, MPH, Andrew A. MD, Andrey S. MD, MPH,